<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01503970</url>
  </required_header>
  <id_info>
    <org_study_id>017-04-INR</org_study_id>
    <nct_id>NCT01503970</nct_id>
  </id_info>
  <brief_title>Autologous Chondrocyte Transplantation For Articular Cartilage Regeneration</brief_title>
  <official_title>Autologous Chondrocyte Transplantation For Articular Cartilage Regeneration. Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Rehabilitacion</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Council of Science and Technology, Mexico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Nacional de Rehabilitacion</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess safety and efficacy of autologous chondrocyte
      implantation delivered arthroscopically into chondral lesions of the knee using clinical,
      biochemical, and MRI outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Injuries to the articular cartilage of the knee are common. They produce pain and
      deteriotation of patients' quality of life. The management of focal chondral lesions
      continues to be problematic for the treating orthopaedic surgeon. Although many treatment
      options are currently available, none fulfill the criteria for an ideal repair solution: a
      hyaline repair tissue that completely fills the defect and integrates well with the
      surrounding normal cartilage. Autologous chondrocyte implantation is a relatively new
      cell-based treatment method for full-thickness cartilage injuries that in recent years has
      increased in popularity, with different studies showing promising results. Typically, this
      implantation is performed in an open-surgery fashion. In our study the implantation of
      in-house autologous chondrocyte culture is done arthroscopically, situation that may offer
      advantages in surgery associated morbidity and patient recovery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline to different periods in T2 Mapping for cartilage lesions after treatment.</measure>
    <time_frame>3, 6, 9, 12, 18, 24 36 months</time_frame>
    <description>Special magnetic resonance imaging technique for measurement of collagen and water content, it is expressed in milliseconds.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of baseline to different periods in Clinical evaluation</measure>
    <time_frame>0, 10, 30 days, 3, 6, 9, 12, 24, 36 months</time_frame>
    <description>Clinical assessment with validated knee scores, and adverse effects register are taken.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Tear; Knee, Cartilage, Articular</condition>
  <arm_group>
    <arm_group_label>Chondrocyte implantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Arthroscopic matrix encapsulated chondrocyte implantation</intervention_name>
    <description>Each implant of collagen scaffold contains approximately 6,000,000 autologous chondrocytes. This constructs of 10 mm diameter are implanted arthroscopically at the defect.</description>
    <arm_group_label>Chondrocyte implantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with symptomatic chondral lesions of the knee

        Exclusion Criteria:

          -  Inflammatory arthritis

          -  Septic arthritis

          -  Total meniscectomy

          -  Previous microfracture at chondral lesions

          -  Paget

          -  Ochronosis

          -  Acromegalia
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clemente Ibarra, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>INR</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luis Guillermo Ibarra, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>INR</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aldo F Izaguirre, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>INR</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Enrique Villalobos, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>INR</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Rehabilitation Institute</name>
      <address>
        <city>Mexico City</city>
        <zip>14389</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Masri M, Lombardero G, Velasquillo C, Martínez V, Neri R, Villegas H, Ibarra C. Matrix-encapsulation cell-seeding technique to prevent cell detachment during arthroscopic implantation of matrix-induced autologous chondrocytes. Arthroscopy. 2007 Aug;23(8):877-83.</citation>
    <PMID>17681210</PMID>
  </reference>
  <reference>
    <citation>Ibarra-Ponce de León JC, Velasquillo-Martínez MC, Izaguirre A, Villalobos-Córdova E, Masri M, Ibarra-Ibarra LG. [Cartilage repair: cell-based techniques]. Acta Ortop Mex. 2009 Jan-Feb;23(1):38-44. Review. Spanish.</citation>
    <PMID>19462773</PMID>
  </reference>
  <reference>
    <citation>Ibarra C, Izaguirre A, Villalobos E, Masri M, Lombardero G, Martinez V, Velasquillo C, Meza AO, Guevara V, Ibarra LG. Follow-up of a new arthroscopic technique for implantation of matrix-encapsulated autologous chondrocytes in the knee. Arthroscopy. 2014 Jun;30(6):715-23. doi: 10.1016/j.arthro.2014.02.032. Epub 2014 Apr 18.</citation>
    <PMID>24746406</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2011</study_first_submitted>
  <study_first_submitted_qc>January 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 4, 2012</study_first_posted>
  <last_update_submitted>April 11, 2017</last_update_submitted>
  <last_update_submitted_qc>April 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Rehabilitacion</investigator_affiliation>
    <investigator_full_name>Aldo Izaguirre</investigator_full_name>
    <investigator_title>Study Director</investigator_title>
  </responsible_party>
  <keyword>chondral lesions</keyword>
  <keyword>knee</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

